Altered Expression of Neurotensin Receptors Is Associated with the Differentiation State of Prostate Cancer

Abstract excerpt

In prostate cancer, traditional treatments such as androgen response manipulation often provide only temporary resolution of disease, with emergence of a more aggressive, androgen-independent tumor following initial therapy. To treat recurrent disease, cell surface proteins that are specifically overexpressed on malignant cells may be useful for generating targeted therapeutics. Recent evidence suggests that...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Neuropeptides and Animal Physiology
• Share to Peptidase Inhibition and Analysis
• Share to Receptor Mechanisms and Signaling